Jesus Castilla

Summary

Country: Spain

Publications

  1. ncbi request reprint Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    J Acquir Immune Defic Syndr 40:96-101. 2005
  2. pmc Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Leyre 15, 31003, Pamplona, Spain
    BMC Public Health 13:191. 2013
  3. doi request reprint Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 30:195-200. 2012
  4. ncbi request reprint [Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000-2005). Impact of the conjugate vaccine]
    Aurelio Barricarte
    Instituto de Salud Publica de Navarra, Pamplona, Navarra, Espana
    Med Clin (Barc) 129:41-5. 2007
  5. doi request reprint Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 29:5919-24. 2011
  6. doi request reprint Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Clin Infect Dis 57:167-75. 2013
  7. doi request reprint Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 30:539-43. 2012
  8. doi request reprint Factors associated with continued adherence to influenza vaccination in the elderly
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Prev Med 55:246-50. 2012
  9. doi request reprint Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain CIBER Epidemiología y Salud Pública CIBERESP, Madrid, Spain Electronic address
    Prev Med 57:206-11. 2013
  10. doi request reprint [Effect of the time between symptom onset, swabbing and testing on the detection of influenza virus]
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Pamplona, Espana
    Enferm Infecc Microbiol Clin 30:11-4. 2012

Detail Information

Publications19

  1. ncbi request reprint Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    J Acquir Immune Defic Syndr 40:96-101. 2005
    ..When HAART became widely available, a reduction of approximately 80% in heterosexual transmission of HIV was observed, irrespective of changes in other factors that affect transmission...
  2. pmc Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Leyre 15, 31003, Pamplona, Spain
    BMC Public Health 13:191. 2013
    ..This study evaluates the effectiveness of the trivalent influenza vaccine in preventing outpatient illness and hospitalizations from laboratory-confirmed influenza in the 2010-2011 season...
  3. doi request reprint Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 30:195-200. 2012
    ..The close estimates obtained in the cohort and the test-negative case-control analyses suggest good control of biases...
  4. ncbi request reprint [Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000-2005). Impact of the conjugate vaccine]
    Aurelio Barricarte
    Instituto de Salud Publica de Navarra, Pamplona, Navarra, Espana
    Med Clin (Barc) 129:41-5. 2007
    ..The 7-valent pneumococcal conjugate vaccine (PCV7) has been commercialized in Spain since June 2001. We aim to evaluate the impact of this vaccine in the incidence of invasive pneumococcal disease (IPD) in Navarre...
  5. doi request reprint Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 29:5919-24. 2011
    ..Pandemic vaccine was effective in preventing MA-ILI and confirmed cases of influenza A(H1N1)2009 in the 2009-2010 season...
  6. doi request reprint Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Clin Infect Dis 57:167-75. 2013
    ..We designed a case-control study to compare the effectiveness of the influenza vaccine in preventing outpatient, inpatient, and severe or fatal cases of laboratory-confirmed influenza...
  7. doi request reprint Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 30:539-43. 2012
    ..No differences between the two vaccines were detected (p=0.4523). Both vaccines were highly effective in preventing cases and hospital admissions in children due to rotavirus gastroenteritis...
  8. doi request reprint Factors associated with continued adherence to influenza vaccination in the elderly
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Prev Med 55:246-50. 2012
    ..We aimed to analyze the factors influencing continued adherence to influenza vaccination in elderly persons vaccinated in the preceding season...
  9. doi request reprint Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain CIBER Epidemiología y Salud Pública CIBERESP, Madrid, Spain Electronic address
    Prev Med 57:206-11. 2013
    ..To evaluate trends in seasonal influenza vaccination coverage in primary healthcare workers (PHCWs) in Spain between 2008 and 2011...
  10. doi request reprint [Effect of the time between symptom onset, swabbing and testing on the detection of influenza virus]
    Iván Martínez-Baz
    Instituto de Salud Publica de Navarra, Pamplona, Espana
    Enferm Infecc Microbiol Clin 30:11-4. 2012
    ..We evaluated the influence on the laboratory results of the time since the onset of symptoms to swabbing (TSS) and from then until laboratory processing (TSL)...
  11. doi request reprint [Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios]
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Leyre 15, Pamplona
    Rev Esp Salud Publica 85:105-11. 2011
    ..A specific vaccination campaign against influenza A (H1N1) was conducted in 2009. We evaluated its impact in Navarre...
  12. doi request reprint Effectiveness of Jeryl Lynn-containing vaccine in Spanish children
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    Vaccine 27:2089-93. 2009
    ..2-8.4) and those who had received the second dose 3 or more years before study enrolment (OR=10.2; 1.5-70.7). Early waning of immunity in children after the second dose may contribute to reduced vaccine effectiveness for mumps prevention...
  13. doi request reprint [Resurgence of mumps in the vaccine era. Factors involved in an outbreak in Navarre, Spain, 2006-2007]
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Espana
    Med Clin (Barc) 133:777-82. 2009
    ..We analysed a mumps outbreak that occurred in Navarre between August 2006 and December 2007, in which vaccinated persons were widely affected...
  14. pmc B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Spain
    J Clin Microbiol 47:463-5. 2009
    ..3 x 10(5) in Navarra, Spain, in 2007. Eleven percent of cases were fatalities, and 74% of cases were individuals 10 to 24 years old. This is the third cluster associated with this strain in northern Spain since 2001...
  15. doi request reprint [Differences between summer and fall waves of influenza in the pandemic of influenza (H1N1) 2009 in Navarre, Spain]
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Leyre 15, Pamplona
    Rev Esp Salud Publica 85:47-56. 2011
    ..Two waves of influenza (H1N1) 2009 were produced in Navarre in 2009, one in the summer and the other in the fall. We aim to compare the characteristics of the two epidemic waves...
  16. ncbi request reprint [Trends in mortality and causes of death among persons with HIV infection, 1985-2004]
    Pablo Aldaz
    Instituto de Salud Publica de Navarra, Departamento de Medicina Preventiva y Salud Publica, Universidad de Navarra, Spain
    Enferm Infecc Microbiol Clin 25:5-10. 2007
    ..To describe the changes in causes of death among persons with HIV infection...
  17. doi request reprint Risk factors and effectiveness of preventive measures against influenza in the community
    Jesus Castilla
    Instituto de Salud Publica de Navarra, 31003 Pamplona, Spain
    Influenza Other Respi Viruses 7:177-83. 2013
    ..The role of different risk exposures and preventive measures against influenza has not been well established...
  18. ncbi request reprint Characteristics and trends of newly diagnosed HIV-infections, 2000-2004
    Jesus Castilla
    Instituto de Salud Publica de Navarra, Pamplona, Espana
    Gac Sanit 20:442-8. 2006
    ..To describe the characteristics and trends of newly diagnosed HIV-infections...
  19. ncbi request reprint Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study
    Aurelio Barricarte
    Instituto de Salud Publica de Navarra, Spain
    Clin Infect Dis 44:1436-41. 2007
    ..The 7-valent pneumococcal conjugate vaccine (PCV7) has shown high efficacy in preventing invasive pneumococcal disease (IPD) caused by vaccine serotypes. We aimed to assess the overall effectiveness of PCV7 against IPD in Navarra, Spain...